Tom A. Yates

Tom A. Yates

Auto-generated profile, based on publicly available information

Tom A. Yates

UCL Institute of Health Informatics, University College London , London

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
TYTom A Yates
Tom A Yates
PKPalwasha Y Khan
Palwasha Y Khan
GKGwenan Knight
Gwenan Knight
JTJonathon Taylor
Jonathon Taylor
TMTimothy McHugh
Timothy McHugh
IAIbrahim Abubakar
Ibrahim Abubakar

27 October 2022 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
PDPaddy C Dempsey
Paddy C Dempsey
ARAlex Rowlands
Alex Rowlands
TSTessa Strain
Tessa Strain
FZFrancesco Zaccardi
Francesco Zaccardi
NDNathan Dawkins
Nathan Dawkins
TYTom Yates
Tom Yates
Aims: The interplay between physical activity (PA) volume and intensity is poorly understood in relation to cardiovascular disease (CVD) risk. This study aimed to investigate the role of PA intensity, over and above volume, in relation to incident CVD. Methods and results: Data were from 88 412 UK Biobank middle-aged adults (58% women) without prevalent CVD who wore accelerometers on their dominant wrist for 7 days, from which we estimated total PA energy expenditure (PAEE) using population-specific validation. Cox proportional hazards regressions modelled associations between PAEE (kJ/kg/day) and PA intensity (%MVPA; the fraction of PAEE accumulated from moderate-to-vigorous-intensity PA) with incident CVD (ischaemic heart disease or cerebrovascular disease), adjusted for potential confounders. There were 4068 CVD events during 584 568 person-years of follow-up (median 6.8 years). Higher PAEE and higher %MVPA (adjusted for PAEE) were associated with lower rates of incident CVD. In interaction analyses, CVD rates were 14% (95% confidence interval: 5–23%) lower when MVPA accounted for 20% rather than 10% of 15 kJ/kg/d PAEE; equivalent to converting a 14 min stroll into a brisk 7 min walk. CVD rates did not differ significantly between values of PAEE when the %MVPA was fixed at 10%. However, the lowest CVD rates were observed for combinations of both higher PAEE and %MVPA. Conclusion: Reductions in CVD risk may be achievable through higher PA volume and intensity, with the role of moderately intense PA appearing particularly important. This supports multiple approaches or strategies to PA participation, some of which may be more practical or appealing to different individuals.

1 March 2019 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
PKPalwasha Y Khan
Palwasha Y Khan
TYTom A Yates
Tom A Yates
MOMuhammad Osman
Muhammad Osman
RWRobin M Warren
Robin M Warren
YHYuri van der Heijden
Yuri van der Heijden
APAlexander Pym
Alexander Pym
The emergence and expansion of the multidrug-resistant tuberculosis epidemic is a threat to the global control of tuberculosis. Multidrug-resistant tuberculosis is the result of the selection of resistance-conferring mutations during inadequate antituberculosis treatment. However, HIV has a profound effect on the natural history of tuberculosis, manifesting in an increased rate of disease progression, leading to increased transmission and amplification of multidrug-resistant tuberculosis. Interventions specific to HIV-endemic areas are urgently needed to block tuberculosis transmission. These interventions should include a combination of rapid molecular diagnostics and improved chemotherapy to shorten the duration of infectiousness, implementation of infection control measures, and active screening of multidrug-resistant tuberculosis contacts, with prophylactic regimens for individuals without evidence of disease. Development and improvement of the efficacy of interventions will require a greater understanding of the factors affecting the transmission of multidrug-resistant tuberculosis in HIV-endemic settings, including population-based molecular epidemiology studies. In this Series article, we review what we know about the transmission of multidrug-resistant tuberculosis in settings with high burdens of HIV and define the research priorities required to develop more effective interventions, to diminish ongoing transmission and the amplification of drug resistance.

1 December 2014 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
RARobert W Aldridge
Robert W Aldridge
TYTom A Yates
Tom A Yates
DZDominik Zenner
Dominik Zenner
PWPeter J White
Peter J White
IAIbrahim Abubakar
Ibrahim Abubakar
AHAndrew C Hayward
Andrew C Hayward
Several high-income countries have pre-entry screening programmes for tuberculosis. We aimed to establish the yield of pre-entry screening programmes to inform evidence-based policy for migrant health screening. We searched six bibliographic databases for experimental or observational studies and systematic reviews, which reported data on migrant screening for active or latent tuberculosis by any method before migration to a low-incidence country. Primary outcomes were principal reported screening yield of active tuberculosis, yield of culture-confirmed cases, and yield of sputum smear for acid-fast bacilli cases. Where appropriate, fixed-effects models were used to summarise the yield of pre-entry screening across included studies. We identified 15 unique studies with data for 3 739 266 migrants screened pre-entry for tuberculosis between 1982 and 2010. Heterogeneity was high for all primary outcomes. After stratification by prevalence in country of origin, heterogeneity was reduced for culture-confirmed and smear-confirmed cases. Yield of culture-confirmed cases increased with prevalence in the country of origin, and summary estimates ranged from 19·7 (95% CI 10·3-31·5) cases identified per 100 000 individuals screened in countries with a prevalence of 50-149 cases per 100 000 population to 335·9 (283·0-393·2) per 100 000 in countries with a prevalence of greater than 350 per 100 000 population. Targeting high-prevalence countries could result in the highest yield for active disease. Pre-entry screening should be considered as part of a broad package of measures to ensure early diagnosis and effective management of migrants with active tuberculosis, and be integrated with initiatives that address the health needs of migrants. Wellcome Trust, UK National Institute for Health Research, Medical Research Council, Public Health England.

10 January 2017 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
FLFinbarr P. Leacy
Finbarr P. Leacy
SFSian Floyd
Sian Floyd
TYTom A. Yates
Tom A. Yates
IWIan R. White
Ian R. White
Multiple imputation with delta adjustment provides a flexible and transparent means to impute univariate missing data under general missing-not-at-random mechanisms. This facilitates the conduct of analyses assessing sensitivity to the missing-at-random (MAR) assumption. We review the delta-adjustment procedure and demonstrate how it can be used to assess sensitivity to departures from MAR, both when estimating the prevalence of a partially observed outcome and when performing parametric causal mediation analyses with a partially observed mediator. We illustrate the approach using data from 34,446 respondents to a tuberculosis and human immunodeficiency virus (HIV) prevalence survey that was conducted as part of the Zambia–South Africa TB and AIDS Reduction Study (2006–2010). In this study, information on partially observed HIV serological values was supplemented by additional information on self-reported HIV status. We present results from 2 types of sensitivity analysis: The first assumed that the degree of departure from MAR was the same for all individuals with missing HIV serological values; the second assumed that the degree of departure from MAR varied according to an individual's self-reported HIV status. Our analyses demonstrate that multiple imputation offers a principled approach by which to incorporate auxiliary information on self-reported HIV status into analyses based on partially observed HIV serological values.

15 December 2015 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
KMKatie Morton
Katie Morton
SSStephen Sutton
Stephen Sutton
WHWendy Hardeman
Wendy Hardeman
JTJacqui Troughton
Jacqui Troughton
TYTom Yates
Tom Yates
HEHelen Eborall
Helen Eborall
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.